'Will it really work?': Young sickle cell patient among the first to start new gene therapy
Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...
3 Unstoppable Stocks to Buy in 2025
You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong ...